Search

Your search keyword '"Spires-Jones, Tara"' showing total 795 results

Search Constraints

Start Over You searched for: Author "Spires-Jones, Tara" Remove constraint Author: "Spires-Jones, Tara"
795 results on '"Spires-Jones, Tara"'

Search Results

1. Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease

2. p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003

3. Author Correction: Microglia regulate central nervous system myelin growth and integrity

4. Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features.

5. Microglia regulate central nervous system myelin growth and integrity

7. Loss of SORCS2 is Associated with Neuronal DNA Double-Strand Breaks

8. Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer’s disease via MFG-E8

9. Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain

12. Blood- and brain-based genome-wide association studies of smoking

13. Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10+16 mutation

14. Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

16. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

17. Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation.

19. Drosophilaappear resistant to trans-synaptic tau propagation

20. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion

22. An epigenetic predictor of death captures multi-modal measures of brain health

24. Reflections on the past two decades of neuroscience

26. A nose for tau.

28. Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer’s Disease

29. Tackling gaps in developing life-changing treatments for dementia

30. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.

31. Author response: Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer’s disease

32. Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003

37. Impact fact(or) fiction?

38. Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features

43. Synaptic oligomeric tau in Alzheimer’s disease – a potential culprit in the spread of tau pathology through the brain

45. Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis

47. Predictive blood biomarkers and brain changes associated with age-related cognitive decline

49. Microglia regulate myelin growth and integrity in the central nervous system

Catalog

Books, media, physical & digital resources